ATE345138T1 - Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen - Google Patents

Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen

Info

Publication number
ATE345138T1
ATE345138T1 AT97945263T AT97945263T ATE345138T1 AT E345138 T1 ATE345138 T1 AT E345138T1 AT 97945263 T AT97945263 T AT 97945263T AT 97945263 T AT97945263 T AT 97945263T AT E345138 T1 ATE345138 T1 AT E345138T1
Authority
AT
Austria
Prior art keywords
heartburn
preventing
compositions
methods
treating heartburn
Prior art date
Application number
AT97945263T
Other languages
English (en)
Inventor
Scott H Korn
Gerard P Mcnally
Joseph R Luber
Tom S Ells
Original Assignee
Merck & Co Inc
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9624291.2A external-priority patent/GB9624291D0/en
Application filed by Merck & Co Inc, Mcneil Ppc Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE345138T1 publication Critical patent/ATE345138T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97945263T 1996-10-04 1997-09-30 Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen ATE345138T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2765996P 1996-10-04 1996-10-04
GBGB9624291.2A GB9624291D0 (en) 1996-11-22 1996-11-22 Methods and compositions for preventions and treating heartburn

Publications (1)

Publication Number Publication Date
ATE345138T1 true ATE345138T1 (de) 2006-12-15

Family

ID=26310458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945263T ATE345138T1 (de) 1996-10-04 1997-09-30 Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen

Country Status (9)

Country Link
EP (1) EP1019066B1 (de)
JP (1) JP2001501224A (de)
AT (1) ATE345138T1 (de)
AU (1) AU728423B2 (de)
CA (1) CA2267503C (de)
DE (1) DE69736955T2 (de)
DK (1) DK1019066T3 (de)
ES (1) ES2274550T3 (de)
WO (1) WO1998014198A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008049195A1 (en) * 2006-10-25 2008-05-02 Iomedix Development International Srl Acute and chronic heartburn composition and method
WO2017091166A1 (en) 2015-11-26 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Stable pharmaceutical compositions and process for their preparation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPH0764737B2 (ja) * 1984-04-19 1995-07-12 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド 制酸組成物
IE58636B1 (en) * 1984-10-17 1993-10-20 American Home Prod Fluidized and rehydratable magaldrate compositions
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
EP0294933B1 (de) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmazeutische Zusammensetzungen
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US5299137A (en) * 1990-04-05 1994-03-29 Vlsi Technology, Inc. Behavioral synthesis of circuits including high impedance buffers
WO1992000102A1 (en) * 1990-06-22 1992-01-09 Beecham Group Plc Novel treatment
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
WO1995001795A1 (en) * 1993-07-06 1995-01-19 Merck & Co., Inc. H2 antagonist-alginate-antacid combinations
AU7255094A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
IT1264546B1 (it) * 1993-07-30 1996-10-02 Lisapharma Spa Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
US5667794A (en) * 1995-05-02 1997-09-16 Merck & Co., Inc. Heartburn treatment

Also Published As

Publication number Publication date
CA2267503C (en) 2002-04-30
CA2267503A1 (en) 1998-04-09
AU728423B2 (en) 2001-01-11
ES2274550T3 (es) 2007-05-16
WO1998014198A1 (en) 1998-04-09
JP2001501224A (ja) 2001-01-30
AU4650697A (en) 1998-04-24
DK1019066T3 (da) 2007-02-26
DE69736955T2 (de) 2007-07-12
EP1019066A4 (de) 2000-07-19
DE69736955D1 (de) 2006-12-28
EP1019066B1 (de) 2006-11-15
EP1019066A1 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
ATE247974T1 (de) Kombinationtherapie mit einem tnf-bindendem protein zür behandlung von durch tnf verursachten erkrangungen
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
CA2289717A1 (en) Novel therapy for constipation
DE69738667D1 (de) Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure
WO2001041707A3 (en) Modulation of in vivo glutamine and glycine levels in the treatment of autism
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
EP0911331A3 (de) Substutierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen, und Anwendungsmethoden
IL131811A0 (en) Antitussive compositions
SE9603725D0 (sv) New teatment
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
ATE345138T1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
DE69733557D1 (de) Endothelin-antagonisten zur behandlung von herzversagen
KR890009413A (ko) Ace억제제를 사용하는 불안 예방 또는 치료 방법
EP0743068A3 (de) Zusammensetzung zur Hemmung von Knochenverlust welche Vanadylsulfat enthält
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1019066

Country of ref document: EP